Prospective study of aspirin use and risk of stroke in women

Stroke

Volumn 30, Issue 9, 1999, Pages 1764-1771

  Iso, Hiroyasu ^a   Hennekens, Charles H ^a   Stampfer, Meir J ^a   Rexrode, Kathryn M ^a   Colditz, Graham A ^b   Speizer, Frank E ^b   Willett, Walter C ^a   Manson, Joann E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Aspirin; Prevention; Primary; Stroke; Stroke classification

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; STROKE;

EID: 0032825255     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.9.1764     Document Type: Article

References (40)

1. Anti-Platelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994:308:81-106.
2. Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K, Warlow C, Hafner B, Thompson E, Norton S, Gilliland J, Doll R. Randomized trial of prophylactic daily aspirin in British male doctors. BMJ. 1988;296:313-316.
3. The Steering Committee of the Physicians' Health Study Research Group. Final report from the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1989;321:129-135.
4. Masotti G, Galanti G, Poggesi L, Abbate R, Neri Serneri GG. Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet. 1979;2:1213-1217.
5. Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest. 1982;69:1366-1372.
6. Patrono C, Ciabattoni G, Patrignani P, Pugliese F, Filabozzi P, Catella F, Davi G, Forni L. Clinical pharmacology of platelet cyclooxygenase inhibition. Circulation. 1985;72:1177-1184.
7. Weksler BB, Pelt SB, Alonso D, Richter RC, Stelzer P, Subramanian V, Tack-Goldman K, Gray WA Jr. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. N EnglJ Med. 19S3;308:800-805.
8. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Aspirin use and chronic diseases: a cohort study of the elderly. BMJ. 1989;299: 1247-1250.
9. Manson JE, Stampfer MJ, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH. A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA. 1991;266: 521-527.
10. Stampfer MJ, Willett WC, Colditz GA, Rosner BA, Speizer FE, Hennekcns CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 1985:313:1044-1049.
11. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51-65.
12. Willett WC, Stampfer MJ. Total energy intake: implications for epidcmiologic analyses. Am J Epidemiol. 1986;124:17-27.
13. Stampfer MJ, Willett WC, Speizer FE, Dysert DC, Lipnick R, Rosner B, Hennekens CH. Test of the National Death Index. Am J Epidemiol. 1984;119:837-839.
14. Walker AE, Robins M, Weinfeld FD. The National Survey of Stroke: clinical findings. Stroke. 1981;! 19:837-839.
15. Anderson CS, Jamrozik KD, Burvill PW, Chakera TMH, Johnson GA, Stewart-Wynne EG. Determining the incidence of different subtypes of stroke: results from the Perth Community Stroke Study, 1989-1990. Med JAust. 1993;158:85-89.
16. D'Agostino RB, Lee M-L, Belanger AJ, Cupples LA, Anderson K, Kännel WB. Relation of pooled logistic regression to time-dependent Cox regression analysis: the Framingham Heart Study. Stat in Med. 1990;9: 1501-1515.
17. Solberg LA, Strong JP. Risk factors and atherosclerosis: a review of autopsy studies. Arteriosclerosis. 1983:3:187-198.
18. Reed DM, Resch JA, Hayashi T, MacLean C, Yano K. A prospective study of cerebral artery atherosclerosis. Stroke. 1988:19:820-825.
19. Konishi M, Iso H, Komachi Y, lida M, Shimamoto T, Jacobs DR Jr, Terao A, Baba S, Sankai T, Ito M. Association of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries: the Akita Pathology Study. Stroke. 1993:24:954-964.
20. Adams RJ, Carroll RM, Nichols FT, McNair N, Feldman DS, Feldman EB, Thompson WO. Plasma lipoproteins in cortical versus lacunar infarction. Stroke. 1989;20:448-452.
21. Giroud M, Boutron MC, Gras P, Gamben P, Lallemant C, Milan C, Essayagh E, Dumas R. Plasma lipoproteins in cortical versus lacunar infarction with or without cardiac arrhythmia, and in transient ischaemic attacks: a case control study. Neural Res. 1992:14:315-320.
22. Heavy DJ, Barrow SE, Hickling NE, Ritter JM. Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man. Nature. 1985;318:186-188.
23. Miller VT, Rothrock JF, Pearce LA, Feinberg WM, Hart RG, Anderson DC. Ischémie stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Neurology. 1993:43:32-36.
24. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet. 1993:342:1255-1262.
25. Yamaguchi T. Comprehensive studies of cerebrovascular disorders. In: Annual Report of the Research on Cardiovascular Diseases, 1992. Osaska, Japan: National Cardiovascular Center; 1993:50-51, and G18 (English abstract).
26. Fisher CM. Capsular infarcts: the underlying vascular lesions. Arch Neural. 1979;36:65-73.
27. Fisher CM. The arterial lesions underlying lacunes. Acta Neuropathol (Bert). 1969;12:1-15.
28. Benhaiem-Sigaux N, Gherardi R, Salama J, Gray F, Amouroux J, Poirier J. Thrombosis of a saccular microaneurysm causing cerebral (pontine) lacunae. Acta Neuropathol (Berl). 1986;69:332-336.
29. Russell RW. Observations on intracerebral aneurysms. Brain. 1963;86: 425-442.
30. Boullin DJ, Buting S, Blaso \VP, Hunt TM, Moncada S. Responses of human and baboon arteries to prostaglandin endoperoxides and biologically generated and synthetic prostacyclin: their relevance to cerebral arterial spasm in man. Br J Clin Pliarmacol. 1979;7:139-147.
31. Handa H, Hashimoto N, Nagata I, Hazama F. Saccular cerebral aneurysms in rats: a newly developed animal model of the disease. Stroke. 1983:14:857-866.
32. Nakatani H, Hashimoto N, Kikuchi H, Yamaguchi S, Niimi H. In vivo flow visualization of induced saccular cerebral aneurysms in rats. Acta Neurochir (Wien). 1993;122:244-249.
33. Shahar E, Folsom AR, Komm FJ, Bisgard KM, Metcalf PA, Crum L, McGovern PG, Hutchinson RG, Heis G, for the ARIC Study Investigators. Patterns of aspirin use in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 1996;131:915-922.
34. Henrich JB, Sandercock PAG, Warlow CP, Jones LN. Stroke and migraine in the Oxfordshire Community Stroke Project. J Neural. 1986; 233:257-262.
35. Ho PC, Triggs EJ, Bourne DWA, Heazlewood VJ. The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites. DrJ Clin Pliarmacol. 1985;19:675-684.
36. Bousser MG, Eschwege E, Haguenau M, Lefaucconnier JM, Thibult N, Touboul D, Touboul PJ. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke. 1983; 14:5-14.
37. The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med. 1978:299:53-59.
38. Candelise L, Landi G, Perrone P, Bracchi M, Brambilla G. A randomized trial of aspirin and sulfinpyrazone in patients with TIA. Stroke. 1982;13: 175-179.
39. UK-TIA Study Group. The United Kingdom Transient Ischémie Attack (UK-TIA) Aspirin Trial: final results. J Neural Neurosurg Psychiatry. 1991:54:1044-1054.
40. Buring JE, Hennekens CH. The Women's Health Study: summary of the study design. J Myocardial Ischemia. 1992:4:27-29.